Can Covid-19 increase the risk of developing Parkinson’s?

News

Author: Caithlin NgPublished: 21 May 2020

Prep: Cook: Serves:

Parkinson’s could be caused or modulated by infections like Covid-19, a new study suggests – though more evidence is needed to draw a definitive conclusion.

As part of the study, researchers from the Federal University of São Paulo, Brazil, drew on previous findings to support their hypothesis. For example, studies in mice have found that infection with some strains of influenza could cause neural changes similar to those in Parkinson’s.

Furthermore, people born during or around the 1918 influenza pandemic were over twice as likely to develop Parkinson’s than those born in the decades before or after.

Patrik Brundin, co-editor-in-chief of the Journal of Parkinson’s Disease, said that while it’s “too early to know what the long-term consequences of Covid-19 will be on the brain, the clinical psychiatry and neurology research communities definitely need to be vigilant in monitoring how those who recover from moderate and severe Covid-19 fare in the future.”

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the EPDA website.

Can higher levels of caffeine and uric acid prevent Parkinson’s?

Last Month

Next Month

Go Back

Share this story

Comments

Resources & Tools

Are pesticides the cause of Parkinson’s disease? Find out in this free podcast

Find out how close we are to knowing the causes

How the drug-addicted William Burroughs inspired a world-renowned Parkinson’s professor

Mentored by a Madman: an exclusive review of Dr Andrew Lees' new book

Fighting Fit: tackling Parkinson’s in the workplace

We talk to the founders of a new programme in Buckinghamshire, UK

Diesel exhaust fumes may increase the risk of Parkinson’s, study suggests

A new study by researchers in the US has found evidence that chemicals in diesel exhaust fumes can damage brain cells – and potentially increase the risk of Parkinson’s. As part of the study – published in ‘Toxicological Sciences’ – researchers tested the effects of diesel exhaust fumes on zebrafish, as their neurons interact in a similar way to those of humans. The researchers found that after being exposed to the chemicals, the zebrafish had fewer cells that dispose of toxic build-up of the protein alpha-synuclein, which occurs in Parkinson’s. The researchers replicated the experiment with cultured human cells and found similar results. Dr Jeff Bronstein, a professor of neurology at the University of California, Los Angeles (UCLA), US, said: “Overall, this report shows a plausible mechanism of why air pollution may increase the risk of Parkinson’s disease.”

Can Covid-19 increase the risk of developing Parkinson’s?

Parkinson’s could be caused or modulated by infections like Covid-19, a new study suggests – though more evidence is needed to draw a definitive conclusion. As part of the study, researchers from the Federal University of São Paulo, Brazil, drew on previous findings to support their hypothesis. For example, studies in mice have found that infection with some strains of influenza could cause neural changes similar to those in Parkinson’s. Furthermore, people born during or around the 1918 influenza pandemic were over twice as likely to develop Parkinson’s than those born in the decades before or after. Patrik Brundin, co-editor-in-chief of the Journal of Parkinson’s Disease, said that while it’s “too early to know what the long-term consequences of Covid-19 will be on the brain, the clinical psychiatry and neurology research communities definitely need to be vigilant in monitoring how those who recover from moderate and severe Covid-19 fare in…

New Parkinson’s trial platform could “dramatically speed up the search for a cure”

Scientists have proposed the use of a multi-arm, multi-stage trial platform (MAMS) to assess different potential treatments for Parkinson’s and help progress the search for a cure. This would depart from conventional clinical procedures, allowing several potential treatments to be assessed simultaneously. In a continuous process, each treatment ‘arm’ is evaluated and unsuccessful ‘arms’ of the trial are dropped, enabling a far more cost and time efficient system. Currently, MAMS are used to evaluate treatments for certain types of cancer – and work is underway to develop MAMS for other neurodegenerative conditions. Camille Buchholz Carroll, associate professor at the University of Plymouth, UK, and study author, said that MAMS trials could “dramatically speed up the search for a cure”. She said: “We have the opportunity to learn from the experience in these other conditions and design a new trial that will work for people with Parkinson’s.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Can Covid-19 increase the risk of developing Parkinson’s?

News

Author: Caithlin NgPublished: 21 May 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Resources & Tools

Are pesticides the cause of Parkinson’s disease? Find out in this free podcast

Perspectives

How the drug-addicted William Burroughs inspired a world-renowned Parkinson’s professor

Interviews

Fighting Fit: tackling Parkinson’s in the workplace

Diesel exhaust fumes may increase the risk of Parkinson’s, study suggests